Ítem
Solo Metadatos

Do your patients suffer from excessive yawning?

Mostrar el registro sencillo de la publicación
dc.creatorGutiérrez?Álvarez, Á. M.spa
dc.date.accessioned2020-05-26T00:03:15Z
dc.date.available2020-05-26T00:03:15Z
dc.date.created2007spa
dc.description.abstractObjective: Yawning has been described in relation to drugs such as serotonin reuptake inhibitors, levodopa, dopamine agonists, MAO B inhibitor, morphine, methadone, buprenorphine, dextromethorphan, benzodiazepine, lidocaine, and flecaine. This is a report of two patients, on long-term escitalopram therapy (more than 8 weeks) with stable dosing, who presented excessive yawning. Escitalopram is widely used in major depressive disorder and generalized anxiety disorder. Method: A clinical description of two cases. Results: Two females (62 and 59 years old, respectively) developed excessive daytime yawning. It was not associated with sedation or a feeling of needing sleep. The dosage was reduced and yawning disappeared some hours later. The patients' depression did not recur. Conclusion: Yawning has been described in relation to different selective serotonin reuptake inhibitors and remitted following their discontinuation; it is interesting that the reported yawning in these two cases disappeared with the reduction of dosage, rather than the interruption of treatment. © 2007 The Authors.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1111/j.1600-0447.2006.00856.x
dc.identifier.issn16000447
dc.identifier.issn0001690X
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23574
dc.language.isoengspa
dc.relation.citationEndPage81
dc.relation.citationIssueNo. 1
dc.relation.citationStartPage80
dc.relation.citationTitleActa Psychiatrica Scandinavica
dc.relation.citationVolumeVol. 115
dc.relation.ispartofActa Psychiatrica Scandinavica, ISSN:16000447, 0001690X, Vol.115, No.1 (2007); pp. 80-81spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-33845731162&doi=10.1111%2fj.1600-0447.2006.00856.x&partnerID=40&md5=6ffc0e95cc5284f61d6a17afbf61d757spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordEscitalopramspa
dc.subject.keywordsecond-generationeng
dc.subject.keywordAdultspa
dc.subject.keywordArticlespa
dc.subject.keywordCase reportspa
dc.subject.keywordClinical examinationspa
dc.subject.keywordClinical featurespa
dc.subject.keywordDaytime somnolencespa
dc.subject.keywordDepressionspa
dc.subject.keywordDrug dose reductionspa
dc.subject.keywordExcessive yawningspa
dc.subject.keywordFemalespa
dc.subject.keywordHumanspa
dc.subject.keywordLong term carespa
dc.subject.keywordMalespa
dc.subject.keywordPriority journalspa
dc.subject.keywordSedationspa
dc.subject.keywordSide effectspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordYawningspa
dc.subject.keywordAntidepressive agentseng
dc.subject.keywordCitalopramspa
dc.subject.keywordDepressive disorderspa
dc.subject.keywordDose-response relationshipeng
dc.subject.keywordFemalespa
dc.subject.keywordHumansspa
dc.subject.keywordMiddle agedspa
dc.subject.keywordSerotonin uptake inhibitorsspa
dc.subject.keywordYawningspa
dc.subject.keywordCase reportsspa
dc.subject.keywordCitalopramspa
dc.subject.keywordDrug effectsspa
dc.subject.keywordYawningspa
dc.titleDo your patients suffer from excessive yawning?spa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos